U.S. flag

An official website of the United States government

GTR Home > Genes

APP amyloid beta precursor protein

Gene ID: 351, updated on 14-Nov-2024
Gene type: protein coding
Also known as: AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; preA4; CTFgamma; alpha-sAPP

Summary

This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
Alzheimer diseasenot available
Alzheimer disease type 1not available
Cerebral amyloid angiopathy, APP-related
MedGen: C2751536OMIM: 605714GeneReviews: Not available
not available

Genomic context

Location:
21q21.3
Sequence:
Chromosome: 21; NC_000021.9 (25880550..26171128, complement)
Total number of exons:
20

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.